Literature DB >> 17983963

Neuroimaging: technologies at the interface of genes, brain, and behavior.

Kristin L Bigos1, Ahmad R Hariri.   

Abstract

Neuroimaging technologies provide a powerful approach to exploring the genetic basis of individual differences in complex behaviors and vulnerability to neuropsychiatric illness. Functional MRI studies have established important physiologic links between genetic polymorphisms and robust differences in information processing within distinct brain regions and circuits that have been linked to the manifestation of various disease. Neuroimaging technologies represent a critical tool in efforts to understand the neurobiology of normal and pathologic behavioral states. Research capitalizing on neuroimagingbased integration will contribute to the identification of predictive markers and biologic pathways for neuropsychiatric disease vulnerability and the generation of novel targets for therapeutic intervention.

Entities:  

Mesh:

Year:  2007        PMID: 17983963      PMCID: PMC2121667          DOI: 10.1016/j.nic.2007.09.005

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  52 in total

1.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

Review 2.  The genetic basis of complex human behaviors.

Authors:  R Plomin; M J Owen; P McGuffin
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

Review 4.  At issue: genes, experience, and chance in schizophrenia--positioning for the 21st century.

Authors:  S O Moldin; I I Gottesman
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

5.  Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation.

Authors:  T Canli; E Congdon; L Gutknecht; R T Constable; K P Lesch
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

Review 6.  Regional and cellular fractionation of working memory.

Authors:  P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

8.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

9.  Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia.

Authors:  Tomas Furmark; Maria Tillfors; Håkan Garpenstrand; Ina Marteinsdottir; Bengt Långström; Lars Oreland; Mats Fredrikson
Journal:  Neurosci Lett       Date:  2004-05-27       Impact factor: 3.046

10.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

Authors:  G W Small; J C Mazziotta; M T Collins; L R Baxter; M E Phelps; M A Mandelkern; A Kaplan; A La Rue; C F Adamson; L Chang
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

View more
  10 in total

Review 1.  Pharmacokinetics in geriatric psychiatry.

Authors:  Kristin L Bigos; Marci L Chew; Robert R Bies
Journal:  Curr Psychiatry Rep       Date:  2008-02       Impact factor: 5.285

Review 2.  Neurobiology of cognitive aging: insights from imaging genetics.

Authors:  Venkata S Mattay; Terry E Goldberg; Fabio Sambataro; Daniel R Weinberger
Journal:  Biol Psychol       Date:  2008-04-11       Impact factor: 3.251

3.  Genetics and brain morphology.

Authors:  Lachlan T Strike; Baptiste Couvy-Duchesne; Narelle K Hansell; Gabriel Cuellar-Partida; Sarah E Medland; Margaret J Wright
Journal:  Neuropsychol Rev       Date:  2015-03-14       Impact factor: 7.444

4.  Genetic variation in CACNA1C affects brain circuitries related to mental illness.

Authors:  Kristin L Bigos; Venkata S Mattay; Joseph H Callicott; Richard E Straub; Radhakrishna Vakkalanka; Bhaskar Kolachana; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-09

5.  Individual Variability in Brain Activity: A Nuisance or an Opportunity?

Authors:  John Darrell Van Horn; Scott T Grafton; Michael B Miller
Journal:  Brain Imaging Behav       Date:  2008-12-01       Impact factor: 3.978

Review 6.  Developmental imaging genetics: linking dopamine function to adolescent behavior.

Authors:  Aarthi Padmanabhan; Beatriz Luna
Journal:  Brain Cogn       Date:  2013-10-17       Impact factor: 2.310

7.  CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder.

Authors:  Alejandra Monserrat Rodríguez-Ramírez; Fátima Meza-Urzúa; Valente Cedillo-Ríos; Claudia Becerra-Palars; Joanna Jiménez-Pavón; Ingrid Pamela Morales-Cedillo; Marco Antonio Sanabrais-Jiménez; Sandra Hernández-Muñoz; Beatriz Camarena-Medellín
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

Review 8.  Clinical significance of knowledge about the structure, function, and impairments of working memory.

Authors:  Andrzej Brodziak; Adam Brewczyński; Grzegorz Bajor
Journal:  Med Sci Monit       Date:  2013-05-03

9.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

Review 10.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.